News
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
David Hallal, Scholar Rock CEO, joins 'Fast Money' to talk its recent drug study results that found its drug taken in ...
Weight loss jabs: Why only 'small percentage' of population will get treatment - and who is eligible
"These treatments are only available on the NHS under strict criteria, and access will be through specialist NHS weight ...
The so-called 'King Kong' of weight-loss drugs can cause side effects like nausea, but may also help users build healthy ...
For those seeking weight loss and improved well-being, a simple ginger lemon water with chia seeds offers a delicious and ...
It’s scary to think that we may have been using a surrogate — BMI — that may not have been all that accurate over the years," ...
Discover age-old Ayurvedic remedies for weight loss, bypassing dietary supplements and rigorous workouts. Incorporate Guggul ...
Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025 ...
The Weight Loss Revolution— that’s released on Wednesday provides a detailed insight into these weight management drugs and ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results